临床儿科杂志 ›› 2016, Vol. 34 ›› Issue (5): 393-.doi: 10.3969 j.issn.1000-3606.2016.05.018
• 文献综述 • 上一篇 下一篇
张静1 ,陈虹2 综述 陈瑞敏2 审校
收稿日期:
出版日期:
发布日期:
Reviewer: ZHANG Jing1, CHEN Hong2, Reviewer: CHEN Ruimin2
Received:
Online:
Published:
摘要： 大部分新生儿糖尿病（NDM）发柄与基因突变有关，部分NDM应用磺脲类药物治疗可取得良好疗效。新近研究从分子水平上阐明了NDM的发病机制及磺脲类药物的作用机制。另有研究表明糖化白蛋白是反映NDM血糖控制的有用指标。文章综述近年对NDM研究的进展。
Abstract: Most neonatal diabetes mellitus (NDM) is caused by genetic abnormality. Sulfonylurea (SU) has been successfully applied in NDM patients; The pathogenesis of NDM and mechanism of sulfonylurea on molecular level have been illuminated, and recent studies revealed that glycated albumin is a useful glycemic indicator. In this review, the research progress of NDM is summarized.
张静,陈虹. 新生儿糖尿病研究进展[J]. 临床儿科杂志, 2016, 34(5): 393-.
ZHANG Jing, CHEN Hong. Progress on neonatal diabetes mellitus[J]. , 2016, 34(5): 393-.
0 / / 推荐
导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks
链接本文: https://jcp.xinhuamed.com.cn/CN/10.3969 j.issn.1000-3606.2016.05.018
https://jcp.xinhuamed.com.cn/CN/Y2016/V34/I5/393
Cited
沪公网安备 31011002000392号
